Cargando…

Perioperative Levosimendan Infusion in Patients With End-Stage Heart Failure Undergoing Left Ventricular Assist Device Implantation

Left ventricular assist device (LVAD) therapy has been instrumental in saving lives of patients with end-stage heart failure (HF). Recent generation devices have short-to-mid-term survival rates close to heart transplantation. Unfortunately, up to 1 in 4 patients develop a life-threatening right-sid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelshafy, Mahmoud, Elsherbini, Hagar, Elkoumy, Ahmed, Simpkin, Andrew J., Elzomor, Hesham, Caliskan, Kadir, Soliman, Osama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095918/ https://www.ncbi.nlm.nih.gov/pubmed/35571194 http://dx.doi.org/10.3389/fcvm.2022.888136

Ejemplares similares

Temporary Right-Ventricular Assist Devices: A Systematic Review
por: Abdelshafy, Mahmoud, et al.
Publicado: (2022)

Efficacy of levosimendan infusion in patients undergoing a left ventricular assist device implant in a propensity score matched analysis of the EUROMACS registry—the Euro LEVO-LVAD study
por: Abdelshafy, Mahmoud, et al.
Publicado: (2023)

Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients
por: Elsherbini, Hagar, et al.
Publicado: (2021)

Correction to: Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients
por: Elsherbini, Hagar, et al.
Publicado: (2021)

Case report: Transcatheter aortic valve replacement in a large bicuspid anatomy using the XL-Myval 32 mm
por: Elkoumy, Ahmed, et al.
Publicado: (2022)

Core Lab Adjudication of the ACURATE neo2 Hemodynamic Performance Using Computed-Tomography-Corrected Left Ventricular Outflow Tract Area
por: Elkoumy, Ahmed, et al.
Publicado: (2022)

Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer
por: Cronin, Michael, et al.
Publicado: (2023)

Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: a systematic review
por: Lunardi, Mattia, et al.
Publicado: (2022)

Paravalvular Aortic Regurgitation Severity Assessed by Quantitative Aortography: ACURATE neo2 versus ACURATE neo Transcatheter Aortic Valve Implantation
por: Rück, Andreas, et al.
Publicado: (2021)

Effect of levosimendan infusion prior to left ventricular assist device implantation on right ventricular failure
por: Segev, Amitai, et al.
Publicado: (2022)

Myocardial efficiency during levosimendan infusion
por: Voipio-Pulkki, L-M, et al.
Publicado: (2002)

Levosimendan for Perioperative Cardioprotection: Myth or Reality?
por: Santillo, Elpidio, et al.
Publicado: (2018)

One-Year Outcomes after Myval Implantation in Patients with Bicuspid Aortic Valve Stenosis—A Multicentre Real-World Experience
por: Elkoumy, Ahmed, et al.
Publicado: (2023)

Predictors of Conduction Disturbances Requiring New Permanent Pacemaker Implantation following Transcatheter Aortic Valve Implantation Using the Evolut Series
por: Abdelshafy, Mahmoud, et al.
Publicado: (2023)

Levosimendan in Right Ventricular Dysfunction
por: Kapoor, Mukul C.
Publicado: (2023)

Influence of timing of Levosimendan administration on outcomes in cardiac surgery
por: Schiefenhövel, Fridtjof, et al.
Publicado: (2023)

Safety and Efficacy of Myval Implantation in Patients with Severe Bicuspid Aortic Valve Stenosis—A Multicenter Real-World Experience
por: Elkoumy, Ahmed, et al.
Publicado: (2022)

The Role of Levosimendan in Patients with Decreased Left Ventricular Function Undergoing Cardiac Surgery
por: Bozhinovska, Marija, et al.
Publicado: (2016)

Effectiveness of prophylactic levosimendan in high-risk valve surgery patients
por: Ersoy, Ozgur, et al.
Publicado: (2013)

The effect of levosimendan on the right ventricular function in patients with right ventricular dysfunction undergoing mitral valve surgery
por: Bharathi, K.S, et al.
Publicado: (2023)

Case Report: Early Identification of Subclinical Cardiac Tamponade in a Patient With a Left Ventricular Assist Device by the Use of Sublingual Microcirculatory Imaging: A New Diagnostic Imaging Tool?
por: Akin, Sakir, et al.
Publicado: (2022)

Frailty and perioperative patient-reported disability in patients undergoing cardiac surgery: a pilot study
por: Milne, Benjamin, et al.
Publicado: (2022)

Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement
por: Kundra, Tanveer Singh, et al.
Publicado: (2018)

Preoperative Levosimendan therapy reduces postoperative right ventricular failure in patients undergoing left ventricular assist device implantation
por: Sugimura, Yukiharu, et al.
Publicado: (2023)

Efficiency and Safety of Prolonged Levosimendan Infusion in Patients with Acute Heart Failure
por: Aidonidis, Georgios, et al.
Publicado: (2011)

Interchangeability of right ventricular longitudinal shortening fraction assessed by transthoracic and transoesophageal echocardiography in the perioperative setting: A prospective study
por: Beyls, Christophe, et al.
Publicado: (2022)

Peguero Electrocardiographic Left Ventricular Hypertrophy Criteria and Risk of Mortality
por: Afify, Hesham M. A., et al.
Publicado: (2018)

The Perioperative Use of Levosimendan as a Means of Optimizing the Surgical Outcome in Patients with Severe Heart Insufficiency Undergoing Cardiac Surgery
por: Leivaditis, Vasileios, et al.
Publicado: (2023)

Perioperative management of aortic stenosis in patients undergoing non-cardiac surgery
por: Herrera, Roberto A., et al.
Publicado: (2023)

Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
por: Chen, Yu-Wen, et al.
Publicado: (2022)

Is there any difference in the therapeutic effects of Levosimendan on advanced HFrEF patients with sinus rhythm or atrial fibrillation?
por: Wang, Wenyan, et al.
Publicado: (2023)

Repetitive Infusion of Levosimendan in Patients with Chronic Heart Failure: A Meta-Analysis
por: Yi, Gui-yan, et al.
Publicado: (2015)

Intermittent levosimendan infusions in advanced heart failure: a real world experience
por: Ortis, Benedetta, et al.
Publicado: (2017)

Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery: An Update Meta-Analysis and Trial Sequential Analysis
por: Wang, Benji, et al.
Publicado: (2018)

Levosimendan in acute heart failure with severely reduced kidney function, a propensity score matched registry study
por: Rottmann, Felix Arne, et al.
Publicado: (2022)

Effects of levosimendan/furosemide infusion on Plasma Brain Natriuretic Peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients
por: Feola, Mauro, et al.
Publicado: (2011)

Quantitative aortography for assessment of aortic regurgitation in the era of percutaneous aortic valve replacement
por: Abdelshafy, Mahmoud, et al.
Publicado: (2023)

Right heart failure syndrome
por: Soliman, Osama, et al.
Publicado: (2018)

No relationship between left ventricular radial wall motion and longitudinal velocity and the extent and severity of noncompaction cardiomyopathy
por: Caliskan, Kadir, et al.
Publicado: (2012)

Levosimendan in patients with low ejection fraction undergoing cardiac surgery
por: Kucewicz-Czech, Ewa M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pf4vs4fg2oornet7n9avl8f2fi